Showing results (1541-1550 of 1,613) with videos related to

Sort By:
Pageof 162
JAMA Oncology|October 25, 2019
Efficacy, Safety, and Tolerability of Pertuzumab, Trastuzumab, and Docetaxel for Patients With Early or Locally Advanced ERBB2-Positive Breast Cancer in Asia: The PEONY Phase 3 Randomized Clinical TrialZhimin Shao, Da Pang, Hongjian Yang, et al.
JAMA Oncology|November 17, 2022
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort TrialLinda M Liau, Keyoumars Ashkan, Steven Brem, et al.
JAMA Oncology|November 17, 2022
Avelumab Plus Talazoparib in Patients With BRCA1/2- or ATM-Altered Advanced Solid Tumors: Results From JAVELIN BRCA/ATM, an Open-Label, Multicenter, Phase 2b, Tumor-Agnostic TrialAlison M Schram, Nicoletta Colombo, Edward Arrowsmith, et al.
JAMA Oncology|February 12, 2026
Salvage Focal Therapy vs Radical Prostatectomy for Localized Radiorecurrent Prostate CancerAlexander Light, Max Peters, Manit Arya, et al.
JAMA Oncology|December 26, 2025
Enhancement of Patient-Centered Lung Cancer Screening: The MyLungHealth Randomized Clinical TrialPolina V Kukhareva, Haojia Li, Christian Balbin, et al.
JAMA Oncology|May 1, 2020
A Phase 2 Multi-institutional Study of Nivolumab for Patients With Advanced Refractory Biliary Tract CancerRichard D Kim, Vincent Chung, Olatunji B Alese, et al.
JAMA Oncology|August 21, 2025
Predicting Chronic Kidney Disease After Cisplatin Treatment Using Population-Level DataRobert C Grant, Jiang Chen He, Ning Liu, et al.
JAMA Oncology|March 2, 2023
First-line Systemic Treatment Options for Metastatic Castration-Sensitive Prostate Cancer: A Living Systematic Review and Network Meta-analysisIrbaz Bin Riaz, Syed Arsalan Ahmed Naqvi, Huan He, et al.
JAMA Oncology|February 16, 2023
Association of a Mediterranean Diet With Outcomes for Patients Treated With Immune Checkpoint Blockade for Advanced MelanomaLaura A Bolte, Karla A Lee, Johannes R Björk, et al.
JAMA Oncology|August 14, 2020
Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Women With Triple-Negative Breast Cancer: A Phase 3 Randomized Clinical TrialKe-Da Yu, Fu-Gui Ye, Min He, et al.
Pageof 162